Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 18.80
+0.10 (0.53%)
Aug 5, 2025, 1:44 PM HKT
ShockWave Medical Market Cap
Sinopharm Group has a market cap or net worth of 58.36 billion as of August 4, 2025. Its market cap has decreased by -5.56% in one year.
Market Cap
58.36B
Enterprise Value
146.47B
Revenue
620.68B
Ranking
n/a
PE Ratio
7.69
Stock Price
$18.80
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 58.36B, an increase of 44.36%. That is a compound annual growth rate of 2.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 58.36B | -12.21% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | 58.86B | -30.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 278.50B |
| Hansoh Pharmaceutical Group Company | 207.51B |
| Innovent Biologics | 158.98B |
| JD Health International | 156.01B |
| Akeso | 140.29B |
| Sino Biopharmaceutical | 130.92B |
| WuXi Biologics | 127.57B |
| CSPC Pharmaceutical Group | 113.07B |